2022 2022 Winner | Venture Winner Science Start-ups (Falling Walls Venture) is the first company to go from biobank data all the way to a clinical trial phase 2b. Purely computationally, they found a potential COVID-19 treatment via what they call synthetic clinical trials, without a single wet lab experiment, for a fraction of the cost and time usually needed. In addition to the drug in phase 2b, their talented team also has molecules in several disease areas in pre-clinical and phase 1.

Content by this speaker

Explore more content of Falling Walls

Further Activities to have a look at